Rani Therapeutics Holdings, Inc. (RANI)
1.07
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.08
+0.01
(+0.93%)
After-Hours: 20:00
Rani Therapeutics Holdings Profit Margin (Quarterly) : -469.3% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
| Veru, Inc. | -- |
| IGC Pharma, Inc. | -757.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -358.1% |
| Return on Assets | -112.0% |
| Return on Invested Capital | -146.5% |
| Gross Profit Margin (Quarterly) | 90.57% |
| Operating Margin (Quarterly) | -488.2% |
| Return on Net Operating Assets | -587.2% |